These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35854087)

  • 41. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Outcomes of Less Invasive Surfactant Administration in Prematurely Born Infants in the Delivery Suite and the Neonatal Unit.
    Shetty S; Tolentino D; Kulkarni A; Duffy D; Greenough A
    Am J Perinatol; 2024 May; 41(S 01):e2674-e2678. PubMed ID: 37500076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimal invasive surfactant therapy in preterm infants with respiratory distress syndrome: a single-center experience.
    Rallis D; Drogouti E; Karagianni P; Soubasi-Griva V; Tsakalidis C
    Minerva Pediatr (Torino); 2024 Feb; 76(1):72-78. PubMed ID: 33820400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive high-frequency oscillatory ventilation versus nasal continuous positive airway pressure in preterm infants with moderate-severe respiratory distress syndrome: A preliminary report.
    Zhu XW; Zhao JN; Tang SF; Yan J; Shi Y
    Pediatr Pulmonol; 2017 Aug; 52(8):1038-1042. PubMed ID: 28672094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of less invasive surfactant administration on cerebral oxygenation in preterm infants.
    Hanke K; Rausch TK; Paul P; Hellwig I; Krämer C; Stichtenoth G; Herz A; Wieg C; König IR; Göpel W; Herting E; Härtel C
    Acta Paediatr; 2020 Feb; 109(2):291-299. PubMed ID: 31310677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Less invasive surfactant administration (LISA): chances and limitations.
    Herting E; Härtel C; Göpel W
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F655-F659. PubMed ID: 31296694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developmental outcome of extremely preterm infants is improved after less invasive surfactant application: Developmental outcome after LISA.
    Mehler K; Broer A; Roll C; Göpel W; Wieg C; Jahn P; Teig N; Höhn T; Welzing L; Vochem M; Hoppenz M; Bührer C; Franklin J; Roth B; Herting E; Kribs A
    Acta Paediatr; 2021 Mar; 110(3):818-825. PubMed ID: 32892376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementation of less-invasive surfactant administration in a Canadian neonatal intensive care unit.
    Bensouda B; St-Hilaire M; Mandel R; Barbier A; Ali N
    Arch Pediatr; 2022 Aug; 29(6):444-447. PubMed ID: 35667998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes following less-invasive-surfactant-administration in the delivery-room.
    Arattu Thodika FMS; Ambulkar H; Williams E; Bhat R; Dassios T; Greenough A
    Early Hum Dev; 2022 Apr; 167():105562. PubMed ID: 35245828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surfactant administration during endotracheal CPAP: Feasibility, risk factors for failure and short-term outcomes of DD-SURF.
    Mense L; Hansmann T; Seipolt B; Kaufmann M; Rüdiger M
    Acta Paediatr; 2023 Aug; 112(8):1653-1658. PubMed ID: 36946356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses.
    Silveira RC; Panceri C; Munõz NP; Carvalho MB; Fraga AC; Procianoy RS
    J Pediatr (Rio J); 2024; 100(1):8-24. PubMed ID: 37353207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caffeine and Less Invasive Surfactant Administration for Respiratory Distress Syndrome of the Newborn.
    Katheria A; Ines F; Banerji A; Hopper A; Uy C; Chundu A; Coughlin K; Hutson S; Morales A; Sauberan J; Poeltler D; Dorner R; Rich W; Finer N
    NEJM Evid; 2023 Dec; 2(12):EVIDoa2300183. PubMed ID: 38320499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence, predictors of success and outcome of LISA in very preterm infants.
    Balazs G; Balajthy A; Riszter M; Kovacs T; Szabo T; Belteki G; Balla G
    Pediatr Pulmonol; 2022 Jul; 57(7):1751-1759. PubMed ID: 34931458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bronchopulmonary dysplasia in preterm infants managed with non-invasive ventilation or surfactant and a brief period of mechanical ventilation: a 6-year cohort study.
    König K; Guy KJ
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):608-11. PubMed ID: 23834679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomised controlled trial in preterm infants comparing prophylactic with selective "less invasive surfactant administration" (pro.LISA).
    Göpel W; Rausch TK; Mitschdörfer B; Mader S; Herting E; König IR; Stichtenoth G;
    Trials; 2023 Sep; 24(1):612. PubMed ID: 37752593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.